Older adults with T2D and chronic kidney disease who lack regular blood pressure monitoring in the 2 years before diagnosis ...
Adults in rural villages in China who participated in the Healthy Family Program, a family-based intervention that involved ...
Black adults living in communities with few grocery stores who participated in a grocery support program providing ...
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney ...
Positive full results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ambulatory 24-hour average systolic blood ...
Switching from a higher to a lower-sodium dose of Xywav led to significant reductions in 24-hour blood pressure for ...
Free home-delivered groceries tailored to the low-sodium Dietary Approaches to Stop Hypertension diet improved blood pressure ...
"AHA 2025: sacubitril/valsartan shows dual edges in resistant hypertension" was originally created and published by ...
News-Medical.Net on MSN
Using estimated risks and preferences to justify intensive BP control in CKD patients
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney ...
AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in ...
A new blood pressure calculator built on extensive clinical trial data helps doctors accurately estimate how much each medication will reduce blood pressure. The tool simplifies complex treatment ...
Financial incentives doubled consistent medication use, with 71% of participants in the rewards group opening their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback